Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer

European Journal of Cancer

Volumn 31, Issue 2, 1995, Pages 230-237

  Baguley, B C ^a   Marshall, E S ^a   Whittaker, J R ^b   Dotchin, M C ^b   Nixon, J ^c   McCrystal, M R ^c   Finlay, G J ^a   Matthews, J H L ^c   Holdaway, K M ^a   van Zijl, P ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b GREEN LANE HOSPITAL   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

antitumour; cell lines; doubling time; paclitaxel

Indexed keywords

PACLITAXEL;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GLUTATHIONE; HUMAN; MIDDLE AGE; OVARIAN NEOPLASMS; PACLITAXEL; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0028904536     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(94)00472-H     Document Type: Article

References (28)

1. Chemotherapy for ovarian cancer
2. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
3. A phase II trial of taxol in metastatic melanoma
4. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer
5. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
6. Plant antitumor agents. VI. The isolation and structure of taxol a novel antileukemic and antitumor agent from Taxus brevifolia
7. Taxol stabilizes microtubules in mouse fibroblast cells
8. Taxol: an antimitotic agent with a new mechanism of action
9. Taxol: a novel investigational antimicrotubule agent
10. Taxol—a review of its preclinical in vivo antitumor activity
11. Mechanism of action of taxol
12. The biochemistry of P-glycoprotein-mediated multidrug resistance
13. Development of polyploidization in taxol-resistant human leukemia cells in vitro
14. Glutathione depletion of l-buthionine sulfoximine antagonizes taxol cytotoxicity
15. Microculture-based chemosensitivity testing: a feasibility study comparing freshly explained human melanoma cells with human melanoma cell lines
16. Cytokinetic differences in the action of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide as compared with that of amsacrine and doxorubicin
17. Anticancer drug sensitivity profiles of new and established melanoma cell lines
18. Enzymic method of quantitative determination of nanogram amounts of total oxidized glutathione: applications to mammalian blood and other tissues
19. Cytotoxic studies of paclitaxel (taxol(r)) in human tumour cell lines
20. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening
21. G1 events and regulation of cell proliferation
22. Do cells cycle?
23. Simple and complex cell cycles
24. Phase I clinical and pharmacokinetic study of taxol
25. Phase I trial of intraperitoneal taxol: a Gynecologic Oncology Group study
26. Disposition of amsacrine and its analogue 9-((2-methoxy-4-[(methylsulfonyl)-amino] phenyl)amino)-N,5-dimetliyl-4-acridine-carboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice
27. Sequences of taxol and cisplatin: a phase I and pharmacologic study
28. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro